This is a preview of subscription content, log in via an institution to check access.
Notes
Indication-specific Pricing of Pharmaceuticals in The US Health Care System: A Report from the 2015 ICER Membership Policy Summit
Reference
Institute for Clinical and Economic Review. ICER Releases White Paper on Indication-specific Pricing for Drugs. Internet Document : Mar 2016. Available from: URL: http://www.icer-review.org/icer-white-paper-isp/
Rights and permissions
About this article
Cite this article
ICER publishes report on indication-specific pricing. PharmacoEcon Outcomes News 749, 3 (2016). https://doi.org/10.1007/s40274-016-2890-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2890-y